Simplex Trading’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1
Closed -$6K 8421
2019
Q3
$6K Sell
1
-6
-86% -$412 ﹤0.01% 6576
2019
Q2
$40K Sell
7
-44
-86% -$2.61K ﹤0.01% 5060
2019
Q1
$357K Sell
51
-6
-11% -$445 ﹤0.01% 3018
2018
Q4
$367K Buy
57
+43
+307% +$3.01K ﹤0.01% 2513
2018
Q3
$98K Sell
14
-3
-18% -$175 ﹤0.01% 4458
2018
Q2
$85K Buy
+17
New +$675 ﹤0.01% 4476
2018
Q1
Sell
-19
Closed -$2K 7296
2017
Q4
$2K Buy
+19
New +$606 ﹤0.01% 5347

Simplex Trading's GHDX Position: Q3 2019 in Review

Simplex Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 5 shares — an estimated $343 sold.

Simplex Trading first reported a position in GHDX in Q1 2015 and held it in 12 quarters. The position peaked at $230K in Q4 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Simplex Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 5 Genomic Health, Inc. shares in Q3 2019, an estimated $343.
  • Simplex Trading first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 12 quarters.
  • Simplex Trading's Genomic Health, Inc. position peaked at $230K in Q4 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.